Nectagen™ is a small privately held biotechnology company founded in 2007 by David Chao and Richard Suderman. Nectagen's mission is to advance biomedical research by providing researchers with access to innovative technology and fostering a community for exchanging improvements, applications and data.
Nectagen creates open technology platforms that biologists can customize and enhance for the community's benefit. Nectagen develops a critical mass of tools and reagents, supports users' development of new modifications and applications, and ensures open access to the technology for the academic community. Where possible, Nectagen designs its platforms using components that are made available to non-profits on the condition that any modifications and derivatives made by the recipient are in turn made available to other non-profits and Nectagen.